Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Adrenocorticotropic hormone

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T73663 Copy Product Info
🥰Excellent
Adrenocorticotropic hormone (ACTH) is a polypeptide tropic hormone secreted by the anterior pituitary. Adrenocorticotropic hormone stimulates the adrenal cortex to release cortisol via the hypothalamic-pituitary-adrenal (HPA) axis and regulates the production of both cortisol and androgens. This hormone also promotes the progression of sperm development. In gout models, adrenocorticotropic hormone alleviates acute inflammatory responses by inhibiting macrophage polarization toward the M1 phenotype, reducing the production of reactive oxygen species (ROS) and pro-inflammatory cytokines, and protecting mitochondrial function.
Pack SizePriceUSA StockGlobal StockQuantity
5 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Adrenocorticotropic hormone (ACTH) is a polypeptide tropic hormone secreted by the anterior pituitary. Adrenocorticotropic hormone stimulates the adrenal cortex to release cortisol via the hypothalamic-pituitary-adrenal (HPA) axis and regulates the production of both cortisol and androgens. This hormone also promotes the progression of sperm development. In gout models, adrenocorticotropic hormone alleviates acute inflammatory responses by inhibiting macrophage polarization toward the M1 phenotype, reducing the production of reactive oxygen species (ROS) and pro-inflammatory cytokines, and protecting mitochondrial function.
In vitro
Method: Spermatogenic cells were isolated from mouse seminiferous tubules and treated with 100 nM adrenocorticotropic hormone for 5 weeks.
Result: The treatment induced the formation of cell clusters from spermatogenic cells, significantly increased the proportion of pre-meiotic cells (positive for CDH-1, VASA, and MC2R), and upregulated the expression of PLZF, VASA, MC2R, and THY-1 genes [1].
Method: Spermatogenic cells were isolated from mouse seminiferous tubules and treated with 100 nM adrenocorticotropic hormone for 5 weeks.
Result: The treatment significantly increased the proportion of cells positive for the meiotic marker BOULE and its gene expression, while having no significant effect on the proportion of CREM-positive cells. It also increased the proportion of cells positive for the post-meiotic marker ACROSIN but decreased its gene expression, with no effect on the expression of SCP3 or protamine [1].
Method: THP-1 cells were induced to differentiate into macrophages, then stimulated with MSU crystals (100 μg/ml). Thirty minutes later, the cells were treated with adrenocorticotropic hormone (1.25×10⁻⁴ U/ml and 2.5×10⁻⁴ U/ml) or dexamethasone (100 nM) for 48 hours. Flow cytometry was used to detect macrophage phagocytosis, polarization markers (iNOS/Arg-1), and reactive oxygen species levels. qRT-PCR was used to measure the expression of inflammation-related genes.
Result: Adrenocorticotropic hormone dose-dependently inhibited the phagocytic function of MSU-stimulated THP-1 macrophages, promoted the polarization of M1 to M2 macrophages, downregulated the pro-inflammatory factors IL-1β, IL-6, and TNF-α, suppressed ROS production, and upregulated the expression of Arg-1, NR1H2, IL-37, FcγRIIIA, and GAS6, while downregulating the expression of NLRP3, MC2R, and MC3R. Its transcriptional regulatory mechanism was different from that of dexamethasone [2].
In vivo
Method: C57BL/6 mice were divided into three groups. An acute gouty arthritis model was established by injecting MSU crystals (50 μl, 1 mg) into the right footpad joint. Thirty minutes later, different concentrations of adrenocorticotropic hormone (0.25 U/ml and 2.5 U/ml) were subcutaneously injected. Joint swelling was measured 8 hours later, inflammatory cell infiltration in joint tissues was observed by H&E staining, and serum cortisol levels were detected by ELISA.
Result: A high concentration of adrenocorticotropic hormone (2.5 U/ml) significantly alleviated MSU-induced joint swelling and inflammatory cell infiltration in mice, whereas a low concentration (0.25 U/ml) had no significant effect. Serum cortisol levels in the adrenocorticotropic hormone-treated groups showed no significant change compared with the control group, indicating that its anti-inflammatory effect is independent of cortisol synthesis [2].
Chemical Properties
Cas No.9002-60-2
SequenceSer-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe
Sequence ShortSYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: Adrenocorticotropic hormone chemical structure | Adrenocorticotropic hormone in vivo | Adrenocorticotropic hormone in vitro